Celgene, Vertex, Illumina Offer Mixed Outlooks

By | January 12, 2016

Scalper1 News

SAN FRANCISCO — Big biotechs Celgene and Vertex Pharmaceuticals disappointed investors with their 2016 guidance, while gene-sequencing giant Illumina previewed a variety of futuristic products, at a major investor conference Monday. The news at the annual JPMorgan Healthcare Conference in San Francisco, sent Celgene (CELG) and Vertex (VRTX) stocks falling Monday, while Illumina (ILMN) shares rose a fraction. Celgene said Q4 EPS totaled $1.18 a Scalper1 News

Scalper1 News